US Life Science Tools Market Summary
The United States Life Science Tools market is projected to grow significantly from 49.0 USD Billion in 2024 to 159.0 USD Billion by 2035.
Key Market Trends & Highlights
US Life Science Tools Key Trends and Highlights
- The market is expected to experience a compound annual growth rate (CAGR) of 11.3 percent from 2025 to 2035.
- By 2035, the market valuation is anticipated to reach 159.0 USD Billion, indicating robust growth potential.
- In 2024, the market is valued at 49.0 USD Billion, reflecting a strong foundation for future expansion.
- Growing adoption of advanced technologies due to increasing research and development activities is a major market driver.
Market Size & Forecast
2024 Market Size | 49.0 (USD Billion) |
2035 Market Size | 159.0 (USD Billion) |
CAGR (2025-2035) | 11.3% |
Major Players
Illumina, Danaher Corporation, Promega Corporation, BioRad Laboratories, Abbott Laboratories, PerkinElmer, Bruker Corporation, Thermo Fisher Scientific, MilliporeSigma, Agilent Technologies, Eppendorf, GE Healthcare, Merck Group, Waters Corporation, Qiagen